Peter Cram1, Sandeep Vijan, David Katz, A Mark Fendrick. 1. Division of General Medicine, Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, IA, USA. peter-cram@uiowa.edu <peter-cram@uiowa.edu>
Abstract
BACKGROUND/ OBJECTIVE: In-home automated external defibrillators (AEDs) are increasingly recommended as a means for improving survival of cardiac arrests that occur at home. The current study was conducted to explore the relationship between individuals' risk of cardiac arrest and cost-effectiveness of in-home AED deployment. DESIGN: Markov decision model employing a societal perspective. PATIENTS: Four hypothetical cohorts of American adults 60 years of age at progressively greater risk for sudden cardiac death (SCD): 1) all adults (annual probability of SCD 0.4%); 2) adults with multiple SCD risk factors (probability 2%); 3) adults with previous myocardial infarction (probability 4%); and 4) adults with ischemic cardiomyopathy unable to receive an implantable defibrillator (probability 6%). INTERVENTION: Strategy 1: individuals suffering an in-home cardiac arrest were treated with emergency medical services equipped with AEDs (EMS-D). Strategy 2: individuals suffering an in-home cardiac arrest received initial treatment with an in-home AED, followed by EMS. RESULTS: Assuming cardiac arrest survival rates of 15% with EMS-D and 30% with AEDs, the cost per quality-adjusted life-year gained (QALY) of providing in-home AEDs to all adults 60 years of age is 216,000 dollars. Costs of providing in-home AEDs to adults with multiple risk factors (2% probability of SCD), previous myocardial infarction (4% probability), and ischemic cardiomyopathy (6% probability) are 132,000 dollars, 104,000 dollars, and 88,000 dollars, respectively. CONCLUSIONS: The cost-effectiveness of in-home AEDs is intimately linked to individuals' risk of SCD. However, providing in-home AEDs to all adults over age 60 appears relatively expensive.
BACKGROUND/ OBJECTIVE: In-home automated external defibrillators (AEDs) are increasingly recommended as a means for improving survival of cardiac arrests that occur at home. The current study was conducted to explore the relationship between individuals' risk of cardiac arrest and cost-effectiveness of in-home AED deployment. DESIGN: Markov decision model employing a societal perspective. PATIENTS: Four hypothetical cohorts of American adults 60 years of age at progressively greater risk for sudden cardiac death (SCD): 1) all adults (annual probability of SCD 0.4%); 2) adults with multiple SCD risk factors (probability 2%); 3) adults with previous myocardial infarction (probability 4%); and 4) adults with ischemic cardiomyopathy unable to receive an implantable defibrillator (probability 6%). INTERVENTION: Strategy 1: individuals suffering an in-home cardiac arrest were treated with emergency medical services equipped with AEDs (EMS-D). Strategy 2: individuals suffering an in-home cardiac arrest received initial treatment with an in-home AED, followed by EMS. RESULTS: Assuming cardiac arrest survival rates of 15% with EMS-D and 30% with AEDs, the cost per quality-adjusted life-year gained (QALY) of providing in-home AEDs to all adults 60 years of age is 216,000 dollars. Costs of providing in-home AEDs to adults with multiple risk factors (2% probability of SCD), previous myocardial infarction (4% probability), and ischemic cardiomyopathy (6% probability) are 132,000 dollars, 104,000 dollars, and 88,000 dollars, respectively. CONCLUSIONS: The cost-effectiveness of in-home AEDs is intimately linked to individuals' risk of SCD. However, providing in-home AEDs to all adults over age 60 appears relatively expensive.
Authors: T Jared Bunch; Roger D White; Bernard J Gersh; Ryan A Meverden; David O Hodge; Karla V Ballman; Stephen C Hammill; Win-Kuang Shen; Douglas L Packer Journal: N Engl J Med Date: 2003-06-26 Impact factor: 91.245
Authors: Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews Journal: N Engl J Med Date: 2002-03-19 Impact factor: 91.245
Authors: I G Stiell; G A Wells; B J Field; D W Spaite; V J De Maio; R Ward; D P Munkley; M B Lyver; L G Luinstra; T Campeau; J Maloney; E Dagnone Journal: JAMA Date: 1999-04-07 Impact factor: 56.272
Authors: Terry P Brown; Gavin D Perkins; Christopher M Smith; Charles D Deakin; Rachael Fothergill Journal: Resuscitation Date: 2021-10-29 Impact factor: 5.262
Authors: Marcus S Shaker; Elissa M Abrams; John Oppenheimer; Alexander G Singer; Matthew Shaker; Daniel Fleck; Matthew Greenhawt; Evan Grove Journal: Front Cardiovasc Med Date: 2022-02-24